Cargando…
Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression
Innate immune cells are active at the front line of host defense against pathogens and now appear to play a range of roles under non-infectious conditions as well, most notably in cancer. Establishing the balance of innate immune responses is critical for the “flavor” of these responses and subseque...
Autores principales: | Stolk, Dorian, van der Vliet, Hans J., de Gruijl, Tanja D., van Kooyk, Yvette, Exley, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161645/ https://www.ncbi.nlm.nih.gov/pubmed/30298063 http://dx.doi.org/10.3389/fimmu.2018.01990 |
Ejemplares similares
-
Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses
por: Stolk, Dorian A., et al.
Publicado: (2020) -
Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8(+) T Cell Responses via CD169(+) Macrophages and cDC1
por: Grabowska, Joanna, et al.
Publicado: (2021) -
Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccines
por: van Dinther, Dieke, et al.
Publicado: (2017) -
CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
por: King, Lisa A., et al.
Publicado: (2018) -
Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
por: King, Lisa A., et al.
Publicado: (2018)